Skip to main content
European Health and Digital Executive Agency (HaDEA)
Convite à apresentação de propostasFechados

Framework Contract for the Reservation of Capacities and a Priority Right for Manufacturing of Vaccines (EU FAB)

Informação detalhada

Estado
Fechados
Referência
HADEA/2022/CPN/0009
Data de publicação
Data de abertura
Data-limite
Programme Sector
Health
Programme
EU4Health
Tags
HealthUnionMedical researchPharmaceutical industryPublic healthPublic procurementScientific researchTendering

Descrição

Financed by HERA’s annual work plan for 2022, the Commission, in cooperation with HaDEA, is launching EU FAB, with the objective to ensure that sufficient and agile manufacturing capacities for different vaccine types are kept operational and can be activated quickly in case of a public health emergency.

The purpose of this framework contract is to reserve the capacity and a priority right to manufacture vaccines for a minimum of 450 million doses under all lots.

Estimated total value: €160 million

Duration of the contract: 48 months

More information